Elanco Animal Health (ELAN) has issued an announcement.
Elanco Animal Health Incorporated successfully completed the sale of its aquaculture business to Intervet International B.V. for approximately $1.3 billion on July 9, 2024. This significant cash transaction, which was initially agreed upon in February 2024, involved the transfer of assets to Intervet, strengthening Elanco’s financial position and marking a strategic shift for the company.
For detailed information about ELAN stock, go to TipRanks’ Stock Analysis page.
